Amyris Closes Upsized Offering Of $690.0 Million Of 1.50% Convertible Senior Notes Due 2026

EMERYVILLE, Calif.: EMERYVILLE, Calif., Nov. 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, announced that it has closed its offering of 1.50% convertible senior notes due 2026 (the "notes"), for gross proceeds of $690.0...

Click to view original post